And by the end of the decade, J&J is expecting double-digit annual growth, said CEO Joaquin Duato on an analysts' call. Novo Nordisk Reteams Apple's Long/Hodgman Ad Duo To Tout Ozempic in Marketing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results